CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 48 target
Drug / intervention
Metaraminoldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01108874
NCT01108874Phase 2Completed
CompareCT.gov

Up-Down Determination of the ED90 of Metaraminol to Treat Hypotension During Elective Cesarean Section

Federal University of São Paulo·interventional·Posted Apr 22, 2010·Updated Oct 1, 2010

In Brief

A Phase 2 clinical trial evaluating Metaraminol for Hypotension. Completed, enrolled 48 participants across 1 site.

Detailed Summary

The purpose of this study is to find the best dose of metaraminol to be used in patients during elective cesarean sections.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypotension
CountriesBrazil
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 22, 2010
Enrollment StartNov 1, 2009
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 16.2 years ago

Interventions

Metaraminoldrug

Patients will be given metaraminol every time SBP falls below baseline value.